Vasopressin dilates the rat carotid artery by stimulating V1 receptors

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 4, 1998, Pages 637-641

  Rutschmann, Blaise ^a   Evequoz, Dominique ^a   Aubert, Jean François ^a   Brunner, Hans R ^a   Waeber, Bernard ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antagonist; Blood flow; Endothelium; Nitric oxide; Vasoconstriction; Vasodilatation; Vasopressin

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; HALOTHANE; LYPRESSIN; METHOXAMINE; PENTOBARBITAL; VASOPRESSIN; VASOPRESSIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CAROTID ARTERY; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; DRUG SCREENING; ECHOGRAPHY; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; STIMULATION; VASODILATATION;

ANGIOTENSIN II; ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; CAROTID ARTERIES; HEART RATE; HORMONE ANTAGONISTS; INFUSIONS, INTRAVENOUS; LYSINE VASOPRESSIN; MALE; METHOXAMINE; RATS; RATS, WISTAR; RECEPTORS, VASOPRESSIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0031680645     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199810000-00017     Document Type: Article

References (21)

1. Liard JF. Vasopressin in cardiovascular control: role of circulating vasopressin. Clin Sci 1984;67:473-81.
2. Ausiello BA, Skorecki KL, Verkman AS, Bonventre JV. Vasopressin signaling in kidney cells. Kidney Int 1987;31:521-9.
3. Mitchell RH, Kick CJ, Billah MM. Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans 1979;7:861-5.
4. Boyle WA, Segel LD. Direct cardiac effects of vasopressin and their reversal by vascular antagonist. Am J Physiol 1986;251:H734-41.
5. Webb RL, Osborn JW Jr, Cowley AW Jr. Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat. Am J Physiol 1986;251:H1244-51.
6. Gavras I, Gavras H. Role of vasopressin in hypertensive disorders. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology; diagnosis and management. New York: Raven Press, 1995:789-800.
7. Liard JF. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Circ Res 1986;58:631-40.
8. Walker BR. Evidence for a vasodilatory effect of vasopressin in the conscious rat. Am J Physiol 1986;251:H34-9.
9. Katusic ZS, Shepherd JT, Vanhoutte PM. Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res 1984;55:575-9.
10. Onoue H, Nakamura N, Toda N. Endothelium-dependent and independent responses to vasodilators of isolated dog cerebral arteries. Stroke 1988;19:1388-94.
11. Katusic ZS. Endothelial L-arginine pathway and regional cerebral arterial reactivity to vasopressin. Am J Physiol 1992;262:H1557-62.
12. Liard JF. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs. Am J Physiol 1994;266:H99-106.
13. Suzuki Y, Satoh S, Oyama H, Takayasu M, Shibuya M. Regional differences in the vasodilator responses to vasopressin in canine cerebral arteries in vivo. Stroke 1993;24:1049-54.
14. Fluekiger JP, Gremaud G, Waeber B, et al. Measurement of sympathetic nerve activity in the unanesthetised rat. J Appl Physiol 1989;67:250-5.
15. Manning M, Sawyer WH. Synthesis and receptor specificities of vasopressin antagonists. J Cardiovasc Pharmacol 1986;8(suppl 7):S29-35.
16. Tardy Y, Meister JJ, Perret F, Brunner HR, Arditi M. Noninvasive estimate of mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. Clin Phys Physiol Meas 1991;12:39-54.
17. Hayoz D, Rutschmann B, Perret F, et al. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 1992;20:1-6.
18. Lüscher TF, Dubey RK. Endothelium and platelet-derived vasoactive substances: role in the regulation of vascular tone and growth. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis and management. New York: Raven Press, 1995:609-30.
19. Schini VB, Katusic ZS, Vanhoutte PM. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells. J Pharmacol Exp Ther 1990;255:994-1000.
20. G-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats. Br J Pharmacol 1991;102:65-72.
21. Gardiner SM, Compton AM, Bennett T. The effects of infusions of arginine vasopressin or deamino-8-D-arginine vasopressin on common carotid vascular resistance in conscious Long-Evans rats. Br J Pharmacol 1989;97:153-7.